{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T19:30:07Z","timestamp":1795116607551,"version":"4.10.3"},"reference-count":68,"publisher":"Oxford University Press (OUP)","issue":"Supplement_4","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,11,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Human sexual response involves a complex sequencing of interrelated mind\/body processes. Few treatment options exist that address the complex multilayered etiological determinants of female sexual dysfunction (FSD).<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>Review and evaluate the clinical application of centrally acting agents for the treatment of FSD, with particular emphasis on recently released data on bremelanotide.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Review of literature on the treatment of FSD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Approaches to FSD treatment have ranged from psychological counseling through a variety of medical interventions along the physiological pathways of sexual function and dysfunction. Despite a great deal of research, especially into hormonal and vasoactive substances, few therapeutics have broad consistent applicability and have withstood scientific scrutiny. Recent clinical trials have investigated the potential role of agents which act on the central nervous system for the treatment of FSD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>While the recent data supporting the therapeutic use of centrally acting agents as a monotherapy for FSD are cautiously encouraging, there would seem to be tremendous promise for these centrally acting compounds to be integrated with treatment approaches that utilize other pathways in a multilayered, individualized approach to care.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1743-6109.2007.00611.x","type":"journal-article","created":{"date-parts":[[2007,10,24]],"date-time":"2007-10-24T05:54:00Z","timestamp":1193205240000},"page":"280-290","source":"Crossref","is-referenced-by-count":21,"title":["Clinical Application of CNS-Acting Agents in FSD"],"prefix":"10.1093","volume":"4","author":[{"given":"Michael A.","family":"Perelman","sequence":"first","affiliation":[{"name":"NY Weill Medical College of Cornell University , New York, NY , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2007,11,1]]},"reference":[{"key":"2024032600410650400_bb0010","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/S0022-5347(05)67828-7","article-title":"Report of the international consensus development conference on female sexual dysfunction: Definitions and classifications","volume":"163","author":"Basson","year":"2000","journal-title":"J Urol"},{"key":"2024032600410650400_bb0015","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1017\/S1092852900024445","article-title":"Neurochemical aspects of the sexual response cycle","volume":"8","author":"Halaris","year":"2003","journal-title":"CNS Spectr"},{"issue":"3","key":"2024032600410650400_bb0020","first-page":"102","article-title":"Female sexual dysfunction: An update on physiopathology","volume":"26","author":"Imbimbo","year":"2003","journal-title":"J Endocrinol Invest"},{"key":"2024032600410650400_bb0025","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0094-0143(02)00069-1","article-title":"Biology of female sexual function","volume":"29","author":"Munarriz","year":"2002","journal-title":"Urol Clin North Am"},{"key":"2024032600410650400_bb0030","doi-asserted-by":"crossref","DOI":"10.1201\/b14618-23","article-title":"Neuroendocrine factors in sexual desire and motivation","author":"Scepkowski","year":"2005","journal-title":"Women's sexual function and dysfunction"},{"key":"2024032600410650400_bb0035","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.2165\/00003495-200363140-00002","article-title":"Female sexual dysfunction: Potential for pharmacotherapy","volume":"63","author":"Fourcroy","year":"2003","journal-title":"Drugs"},{"key":"2024032600410650400_bb0040","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/j.1743-6109.2006.00285.x","article-title":"Female sexual satisfaction and pharmaceutical intervention: A critical review of the drug intervention studies in female sexual dysfunction","volume":"3","author":"Nijland","year":"2006","journal-title":"J Sex Med"},{"key":"2024032600410650400_bb0045","article-title":"Human sexual inadequacy","author":"Masters","year":"1970"},{"key":"2024032600410650400_bb0050","article-title":"The new sex therapy","author":"Kaplan","year":"1974"},{"key":"2024032600410650400_bb0055","article-title":"Empirically validated treatment for sexual dysfunction","author":"Heiman","year":"1998","journal-title":"Annual review of sex research"},{"key":"2024032600410650400_bb0060","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJM199805143382001","article-title":"Oral sildenafil in the treatment of erectile dysfunction","volume":"338","author":"Goldstein","year":"1998","journal-title":"N Engl J Med"},{"key":"2024032600410650400_bb0065","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1097\/01.ju.0000090966.74607.34","article-title":"Safety and efficacy of sildenafil citrate for the treatment of female sexual arousal disorder: A double-blind, placebo controlled study","volume":"170","author":"Berman","year":"2003","journal-title":"J Urol"},{"key":"2024032600410650400_bb0070","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1089\/152460902317586001","article-title":"Efficacy and safety of sildenafil citrate in women with sexual dysfunction associated with female sexual arousal disorder","volume":"11","author":"Basson","year":"2002","journal-title":"J Womens Health Gend Based Med"},{"key":"2024032600410650400_bb0075","first-page":"165","article-title":"Changes in sexual drives of patients on oral contraceptives","volume":"17","author":"Gambrell","year":"1976","journal-title":"J Reprod Med"},{"key":"2024032600410650400_bb0080","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1479-828X.1978.tb00048.x","article-title":"The effects on sexual response and mood after sterilization of women taking long-term oral contraception: Results of a double-blind cross-over study","volume":"18","author":"Leeton","year":"1978","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"2024032600410650400_bb0085","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0015-0282(02)02969-2","article-title":"Female androgen insufficiency: The Princeton consensus statement on definition, classification, and assessment","volume":"77","author":"Bachmann","year":"2002","journal-title":"Fertil Steril"},{"key":"2024032600410650400_bb0090","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1056\/NEJM200006153422407","article-title":"Erectile dysfunction","volume":"342","author":"Lue","year":"2000","journal-title":"N Engl J Med"},{"key":"2024032600410650400_bb0095","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1006\/bbrc.1998.9206","article-title":"Sildenafil inhibits phosphodiesterase type 5 in human clitoral corpus cavernosum smooth muscle","volume":"249","author":"Park","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"2024032600410650400_bb0100","article-title":"Registry of clinical trials","author":"US Food and Drug Administration","year":"2007"},{"key":"2024032600410650400_bb0105","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1743-6109.2007.00455.x","article-title":"Proposal for changes in diagnostic criteria for sexual dysfunctions","volume":"4","author":"Segraves","year":"2007","journal-title":"J Sex Med"},{"key":"2024032600410650400_bb0110","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1345\/aph.1G472","article-title":"Topical alprostadil treatment of female sexual arousal disorder","volume":"40","author":"Kielbasa","year":"2006","journal-title":"Ann Pharmacother"},{"key":"2024032600410650400_bb0115","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1071\/SH05055","article-title":"A clinical update on female androgen insufficiency\u2014Testosterone testing and treatment in women presenting with low sexual desire","volume":"3","author":"Burger","year":"2006","journal-title":"Sex Health"},{"key":"2024032600410650400_bb0120","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ogc.2006.09.001","article-title":"Female androgen insufficiency","volume":"33","author":"Bachmann","year":"2006","journal-title":"Obstet Gynecol Clin North Am"},{"key":"2024032600410650400_bb0125","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1056\/NEJM200009073431002","article-title":"Transdermal testosterone treatment in women with impaired sexual function after oophorectomy","volume":"343","author":"Shifren","year":"2000","journal-title":"N Engl J Med"},{"key":"2024032600410650400_bb0130","doi-asserted-by":"crossref","first-page":"5226","DOI":"10.1210\/jc.2004-1747","article-title":"Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder","volume":"90","author":"Simon","year":"2005","journal-title":"J Endocrin Metab"},{"key":"2024032600410650400_bb0135","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1001\/archinte.165.14.1582","article-title":"Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: A randomized, placebo-controlled trial","volume":"165","author":"Braunstein","year":"2005","journal-title":"Arch Intern Med"},{"key":"2024032600410650400_bb0140","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1210\/jc.2006-1121","article-title":"Androgen therapy in women: An Endocrine Society Clinical Practice Guideline","volume":"91","author":"Wierman","year":"2006","journal-title":"J Clin Endocrin Metab"},{"key":"2024032600410650400_bb0145","first-page":"1223","article-title":"Are the Endocrine Society's Clinical Practice Guidelines on androgen therapy in women misguided? A commentary","author":"Traish","year":"2007"},{"issue":"3","key":"2024032600410650400_bb0150","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1743-6109.2007.00448.x","article-title":"Hormonal changes in menopause and implications on sexual health","volume":"4","author":"Schwenkhagen","year":"2007","journal-title":"J Sex Med"},{"issue":"3","key":"2024032600410650400_bb0155","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1743-6109.2007.00450.x","article-title":"Current management strategies of the postmenopausal patient with sexual health problems","volume":"4","author":"Goldstein","year":"2007","journal-title":"J Sex Med"},{"key":"2024032600410650400_bb0160","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1067\/mob.2003.117","article-title":"Female sexual dysfunction in postmenopausal women: Systematic review of placebo-controlled trials","volume":"188","author":"Modelska","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"2024032600410650400_bb0165","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1080\/00926230590950217","article-title":"Dopamine and norepinephrine responses to film-induced sexual arousal in sexually functional and sexually dysfunctional women","volume":"31","author":"Meston","year":"2005","journal-title":"J Sex Marital Ther"},{"key":"2024032600410650400_bb0170","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/S0090-4295(01)00992-X","article-title":"Blood-oxygenation-level-dependent functional magnetic resonance imaging for evaluating cerebral regions of female sexual arousal response","volume":"57","author":"Park","year":"2001","journal-title":"Urology"},{"key":"2024032600410650400_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hbm.10014","article-title":"Areas of brain activation in males and females during viewing of erotic film excerpts","volume":"16","author":"Karama","year":"2002","journal-title":"Hum Brain Mapp"},{"key":"2024032600410650400_bb0180","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00221-006-0429-3","article-title":"There are differences in cerebral activation between females in distinct menstrual phases during viewing of erotic stimuli: A fMRI study","volume":"174","author":"Gizewski","year":"2006","journal-title":"Exp Brain Res"},{"key":"2024032600410650400_bb0185","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1080\/10532528.2005.10559829","article-title":"Functional MRI of the brain during orgasm in women","volume":"16","author":"Komisaruk","year":"2005","journal-title":"Ann Rev Sex Res"},{"key":"2024032600410650400_bb0190","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF02938329","article-title":"The role of functional MRI in neural assessment of female sexual dysfunction","volume":"4","author":"Park","year":"2007","journal-title":"Curr Sex Health Rep"},{"key":"2024032600410650400_bb0195","first-page":"373","article-title":"Sexual dysfunction with antihypertensive and antipsychotic agents","volume":"5","author":"Smith","year":"1986","journal-title":"Clin Pharm"},{"key":"2024032600410650400_bb0200","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00004714-199902000-00013","article-title":"Effects of SSRIs on sexual function: A critical review","volume":"19","author":"Rosen","year":"1999","journal-title":"J Clin Psychopharmacol"},{"key":"2024032600410650400_bb0205","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/sj.npp.1300036","article-title":"Changes in human in vivo serotonin and dopamine transporter availabilities during chronic antidepressant administration","volume":"28","author":"Kugaya","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"2024032600410650400_bb0210","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/j.1743-6109.2006.00238.x","article-title":"A new combination treatment for premature ejaculation: A sex therapist's perspective","volume":"3","author":"Perelman","year":"2006","journal-title":"J Sex Med"},{"key":"2024032600410650400_bb0215","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1016\/S0022-5347(05)64146-8","article-title":"The neurobiological approach to premature ejaculation","volume":"168","author":"Waldinger","year":"2002","journal-title":"J Urol"},{"key":"2024032600410650400_bb0220","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.4088\/JCP.v65n0806","article-title":"\u201cDopamine-dependent\u201d side effects of selective serotonin reuptake inhibitors: A clinical review","volume":"65","author":"Damsa","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"2024032600410650400_bb0225","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.biopsych.2005.06.027","article-title":"Use of bupropion in combination with serotonin reuptake inhibitors","volume":"59","author":"Zisook","year":"2006","journal-title":"Biol Psychiatry"},{"key":"2024032600410650400_bb0230","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jad.2005.12.007","article-title":"Burden of phase-specific sexual dysfunction with SSRIs","volume":"9","author":"Clayton","year":"2006","journal-title":"J Affect Disord"},{"key":"2024032600410650400_bb0235","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1176\/appi.ajp.158.5.805","article-title":"Sustained-release bupropion for selective serotonin reuptake inhibitor-induced sexual dysfunction: A randomized, double-blind, placebo-controlled, parallel-group study","volume":"158","author":"Masand","year":"2001","journal-title":"Am J Psychiatry"},{"key":"2024032600410650400_bb0240","doi-asserted-by":"crossref","first-page":"736","DOI":"10.4088\/JCP.v67n0507","article-title":"Bupropion extended release compared with escitalopram: Effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies","volume":"67","author":"Clayton","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"2024032600410650400_bb0245","doi-asserted-by":"crossref","first-page":"844","DOI":"10.4088\/JCP.v66n0706","article-title":"A placebo-controlled, randomized, double-blind study of adjunctive bupropion sustained release in the treatment of SSRI-induced sexual dysfunction","volume":"66","author":"DeBattista","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"2024032600410650400_bb0250","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s11920-006-0047-6","article-title":"Strategies for managing antidepressant-induced sexual dysfunction: A review","volume":"8","author":"Taylor","year":"2006","journal-title":"Curr Psychiatry Rep"},{"key":"2024032600410650400_bb0255","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1527-3458.2002.tb00219.x","article-title":"Pharmacology of flibanserin","volume":"8","author":"Borsini","year":"2002","journal-title":"CNS Drug Rev"},{"key":"2024032600410650400_bb0260","article-title":"Clinical Trials. gov. Clinical Trials registry Web site","year":"2007"},{"key":"2024032600410650400_bb0265","doi-asserted-by":"crossref","first-page":"586","DOI":"10.2174\/1389450033490858","article-title":"Melanocortins and their receptors and antagonists","volume":"4","author":"Voisey","year":"2003","journal-title":"Curr Drug Targets"},{"key":"2024032600410650400_bb0270","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1749-6632.2003.tb03167.x","article-title":"PT-141: A melanocortin agonist for the treatment of sexual dysfunction","volume":"994","author":"Molinoff","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"2024032600410650400_bb0275","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1743-6109.2006.00268.x","article-title":"An Effect on the subjective sexual response in premenopausal women with Sexual Arousal Disorder by bremelanotide (PT-141), a melanocortin receptor agonist","volume":"3","author":"Diamond","year":"2006","journal-title":"J Sex Med"},{"key":"2024032600410650400_bb0280","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1743-6109.2005.00153.x","article-title":"The sensitivity of event logs, self-administered questionnaires and photoplethysmography to detect treatment-induced changes in Female Sexual Arousal Disorder (FSAD) diagnosis","volume":"3","author":"Rellini","year":"2006","journal-title":"J Sex Med"},{"key":"2024032600410650400_bb0285"},{"key":"2024032600410650400_bb0290","article-title":"Empirically validated treatment for sexual dysfunction","author":"Heiman","year":"1998","journal-title":"Annual review of sex research"},{"issue":"1","key":"2024032600410650400_bb0295","first-page":"52","article-title":"The Sexual Tipping PointTM: A model to conceptualize etiology, diagnosis & combination treatment of female and male sexual dysfunction","volume":"3","author":"Perelman","year":"2006","journal-title":"J Sex Med"},{"key":"2024032600410650400_bb0300","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ucl.2005.08.010","article-title":"Psychosocial evaluation and combination treatment of men with erectile dysfunction","volume":"32","author":"Perelman","year":"2005","journal-title":"Urol Clin North Am"},{"key":"2024032600410650400_bb0305","article-title":"Integrated sex therapy: Interplay of behavioral, cognitive, and medical approaches","author":"Perelman","year":"2008","journal-title":"Textbook of erectile dysfunction"},{"key":"2024032600410650400_bb0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02938324","article-title":"Optimizing response to phosphodiesterase type 5 inhibitors","volume":"4","author":"Sadovsky","year":"2007","journal-title":"Curr Sex Health Rep"},{"key":"2024032600410650400_bb0315","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/01.ogx.0000157978.91721.0f","article-title":"Female sexual dysfunction: Principles of diagnosis and therapy","volume":"60","author":"Pauls","year":"2005","journal-title":"Obstet Gynecol Surv"},{"key":"2024032600410650400_bb0320","article-title":"Sexual medicine: Sexual dysfunc tions in men and women","author":"Lue","year":"2004"},{"key":"2024032600410650400_bb0325","article-title":"Psychological and interpersonal dimensions of sexual function and dysfunction","author":"Althof","year":"2004","journal-title":"Sexual medicine: Sexual dysfunctions in men and women"},{"key":"2024032600410650400_bb0330","article-title":"Combination therapy for sexual dysfunction: Integrating sex therapy and pharmacotherapy","author":"Perelman","year":"2005","journal-title":"Handbook of sexual dysfunction"},{"key":"2024032600410650400_bb0335","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1177\/0145445500243002","article-title":"Sexual compatibility and the sexual desire-motivation relation in females with hypoactive sexual desire disorder","volume":"24","author":"Hurlbert","year":"2000","journal-title":"Behav Modif"},{"key":"2024032600410650400_bb0340","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0149-7634(99)00019-6","article-title":"Central inhibition of sexual response in the male: A theoretical perspective","volume":"23","author":"Bancroft","year":"1999","journal-title":"Neurosci Biobehav Rev"},{"key":"2024032600410650400_bb0345","article-title":"Women's sexual function and dysfunction","author":"Goldstein","year":"2006"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S174360951531780X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S174360951531780X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/4\/Supplement_4\/280\/47808790\/jsm_4_supplement_4_280.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/4\/Supplement_4\/280\/47808790\/jsm_4_supplement_4_280.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T21:13:07Z","timestamp":1737493987000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/4\/Supplement_4\/280\/6889670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11,1]]},"references-count":68,"journal-issue":{"issue":"Supplement_4","published-online":{"date-parts":[[2007,11,1]]},"published-print":{"date-parts":[[2007,11,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1743-6109.2007.00611.x","relation":{},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2007,11]]},"published":{"date-parts":[[2007,11,1]]}}}